DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Journey Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$5.17+0.21 (+4.13%)
Close on Oct 19, 2026
- Market cap
- $142.14M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
37.8%
11M of 28M shares
Institutional holders
71
23 new, 23 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Wasatch Advisors LP | 2,449,253 | 11.00% | 13G (passive) amendment | Sep 30, 2026 |
| Tang Capital Management, LLC | 1,854,596 | 8.00% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DERM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Wasatch Advisors LP | 2,858,930 | 10.13% | $20.24M | +725,560 | 0.13% |
| Tang Capital Management LLC | 1,610,000 | 5.70% | $11.40M | – | 0.52% |
| Vanguard Capital Management LLC | 675,185 | 2.39% | $4.78M | −406,895 | 0.00% |
| Punch & Associates Investment Management, Inc. | 536,000 | 1.90% | $3.79M | New | 0.19% |
| Pale Fire Capital SE | 528,584 | 1.87% | $3.74M | +46,597 | 0.26% |
| Opaleye Management Inc. | 350,000 | 1.24% | $2.48M | −610,000 | 0.22% |
| Summit Financial, LLC | 346,748 | 1.23% | $2.45M | −33,059 | 0.03% |
| Jane Street Group, LLC | 320,021 | 1.13% | $2.27M | New | 0.00% |
| Diametric Capital, LP | 295,663 | 1.05% | $2.09M | +99,251 | 0.22% |
| Ikarian Capital, LLC | 251,436 | 0.89% | $1.78M | – | 0.19% |
| Renaissance Technologies LLC | 229,700 | 0.81% | $1.63M | −12,800 | 0.00% |
| Geode Capital Management, LLC | 216,004 | 0.77% | $1.53M | −247,198 | 0.00% |
| American Financial Group Inc | 180,000 | 0.64% | $1.27M | – | 0.45% |
| Trexquant Investment LP | 171,338 | 0.61% | $1.21M | +143,242 | 0.01% |
| Marshall Wace, Llp | 139,843 | 0.50% | $990.09K | New | 0.00% |
| J. Goldman & Co LP | 137,584 | 0.49% | $974.10K | −362,604 | 0.03% |
| Millennium Management LLC | 110,016 | 0.39% | $778.91K | −273,051 | 0.00% |
| BlackRock, Inc. | 100,981 | 0.36% | $714.95K | −871,881 | 0.00% |
| XTX Topco Ltd | 100,923 | 0.36% | $714.54K | +71,559 | 0.01% |
| Vanguard Fiduciary Trust Co | 94,729 | 0.34% | $670.68K | −42,977 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 71 | 11M | 37.8% | 23 / 19 | 23 / 23 | 3M | 4M |
| Q1 2026 | 72 | 12M | 42.0% | 13 / 32 | 18 / 17 | 3M | 2M |
| Q4 2025 | 77 | 11M | 39.1% | 17 / 34 | 14 / 7 | 3M | 0M |
| Q3 2025 | 68 | 9M | 30.8% | 17 / 22 | 16 / 5 | 2M | 0M |
| Q2 2025 | 56 | 6M | 23.0% | 25 / 14 | 11 / 7 | 2M | 1M |
| Q1 2025 | 38 | 5M | 18.0% | 6 / 17 | 7 / 5 | 1M | 0M |
| Q4 2024 | 37 | 4M | 13.4% | 7 / 11 | 9 / 6 | 2M | 0M |
| Q3 2024 | 36 | 2M | 7.6% | 7 / 8 | 10 / 4 | 0M | 0M |
| Q2 2024 | 35 | 2M | 8.4% | 13 / 6 | 6 / 11 | 1M | 0M |
| Q1 2024 | 33 | 2M | 6.4% | 9 / 12 | 7 / 12 | 1M | 0M |
| Q4 2023 | 36 | 1M | 4.8% | 19 / 11 | 3 / 4 | 1M | 2M |
| Q3 2023 | 21 | 2M | 7.6% | 5 / 6 | 7 / 3 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of DERM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Wasatch Micro Cap Fund | 1,295,173 | 4.59% | $9.17M | 1.36% | Jun 30, 2026 |
| Wasatch Micro Cap Value Fund | 788,173 | 2.79% | $5.58M | 1.44% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 470,426 | 1.67% | $3.33M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 186,966 | 0.66% | $1.32M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 105,535 | 0.37% | $665.93K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 104,017 | 0.37% | $656.35K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 50,931 | 0.18% | $360.59K | 0.02% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 41,381 | 0.15% | $261.11K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 28,610 | 0.10% | $180.53K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 19,126 | 0.07% | $120.69K | 0.01% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 14,064 | 0.05% | $88.74K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 10,418 | 0.04% | $73.76K | 0.00% | Jun 30, 2026 |
| Invesco NASDAQ Future Gen 200 ETF | 9,405 | 0.03% | $59.35K | 0.31% | May 31, 2026 |
| Small Cap Index Fund | 8,545 | 0.03% | $53.92K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 7,375 | 0.03% | $52.22K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Claude Maraoui | President & CEO, Director | 2,435,990 | 8.63% | Apr 24, 2026 |
| Ramsey Alloush | Chief Operating Officer | 598,543 | 2.12% | Apr 24, 2026 |
| Joseph Benesch | CFO | 261,371 | 0.93% | Apr 24, 2026 |
| Miranda Jayne Toledano | Director | 168,618 | 0.60% | Jul 2, 2026 |
| Justin Adam Smith | Director | 231,618 | 0.82% | Jul 2, 2026 |
| Neil Herskowitz | Director | 168,618 | 0.60% | Jul 2, 2026 |
| Michael Cooper Pearce | Director | 67,173 | 0.24% | Jun 26, 2026 |
| Lindsay A. Rosenwald Md | Director | 397,616 | 1.41% | Jun 26, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Neil Herskowitz Director | Jul 1, 2026 | Award | +50,000 | – | – | 168,618 |
| Justin Adam Smith Director | Jul 1, 2026 | Award | +50,000 | – | – | 231,618 |
| Miranda Jayne Toledano Director | Jul 1, 2026 | Award | +50,000 | – | – | 168,618 |
| Miranda Jayne Toledano Director | Jun 25, 2026 | Award | +10,000 | – | – | 118,618 |
| Lindsay A. Rosenwald Md Director | Jun 25, 2026 | Award | +10,000 | – | – | 221,146 |
| Michael Cooper Pearce Director | Jun 25, 2026 | Award | +10,000 | – | – | 67,173 |
| Neil Herskowitz Director | Jun 25, 2026 | Award | +10,000 | – | – | 118,618 |
| Justin Adam Smith Director | Jun 25, 2026 | Award | +10,000 | – | – | 181,618 |
| Joseph Benesch CFO | Apr 22, 2026 | Award | +28,907 | – | – | 261,371 |
| Ramsey Alloush Chief Operating Officer | Apr 22, 2026 | Award | +46,863 | – | – | 598,543 |
| Claude Maraoui President & CEO, Director | Apr 22, 2026 | Award | +49,277 | – | – | 2,435,990 |
| Claude Maraoui President & CEO, Director | Aug 25, 2025 | Tax withholding | −10,877 | $7.47 | $81.25K | 2,386,713 |
| Claude Maraoui President & CEO, Director | Aug 25, 2025 | Option exercise | +1,250,000 | $0.07 | $87.50K | 2,397,590 |
| Neil Herskowitz Director | Aug 5, 2025 | Award | +20,000 | – | – | 108,618 |
| Miranda Jayne Toledano Director | Aug 5, 2025 | Award | +20,000 | – | – | 108,618 |
| Lindsay A. Rosenwald Md Director | Aug 5, 2025 | Award | +50,000 | – | – | 211,146 |
| Michael Cooper Pearce Director | Aug 5, 2025 | Award | +20,000 | – | – | 57,173 |
| Justin Adam Smith Director | Aug 5, 2025 | Award | +20,000 | – | – | 171,618 |
| Michael Cooper Pearce Director | Jun 25, 2025 | Award | +7,173 | – | – | 37,173 |
| Lindsay A. Rosenwald Md Director | Jun 25, 2025 | Award | +7,173 | – | – | 161,146 |
| Neil Herskowitz Director | Jun 25, 2025 | Award | +7,173 | – | – | 88,618 |
| Justin Adam Smith Director | Jun 25, 2025 | Award | +7,173 | – | – | 151,618 |
| Miranda Jayne Toledano Director | Jun 25, 2025 | Award | +7,173 | – | – | 88,618 |
| Joseph Benesch CFO | Jun 17, 2025 | Award | +28,907 | – | – | 232,464 |
| Claude Maraoui President & CEO, Director | Jun 17, 2025 | Award | +49,277 | – | – | 2,397,590 |
| Ramsey Alloush Chief Operating Officer | Jun 17, 2025 | Award | +46,863 | – | – | 551,680 |
| Joseph Benesch CFO | May 2, 2025 | Sale | −2,409 | $6.84 | $16.48K | 203,557 |
| Ramsey Alloush COO | May 2, 2025 | Sale | −2,857 | $6.84 | $19.54K | 504,817 |
| Claude Maraoui President & CEO, Director | May 2, 2025 | Sale | −4,834 | $6.84 | $33.06K | 2,348,313 |
| Claude Maraoui President & CEO, Director | Mar 11, 2025 | Sale | −49,271 | $5.01 | $246.85K | 2,003,147 |
| Claude Maraoui President & CEO, Director | Mar 7, 2025 | Sale | −14,905 | $5.01 | $74.67K | 2,052,418 |
| Claude Maraoui President & CEO, Director | Mar 6, 2025 | Sale | −25,551 | $5.04 | $128.78K | 2,067,323 |
| Claude Maraoui President & CEO, Director | Mar 5, 2025 | Sale | −18,147 | $5.13 | $93.09K | 2,092,874 |
| Claude Maraoui President & CEO, Director | Mar 4, 2025 | Sale | −28,901 | $5.04 | $145.66K | 2,111,021 |
| Claude Maraoui President & CEO, Director | Mar 3, 2025 | Sale | −23,508 | $5.19 | $122.01K | 2,139,922 |
| Joseph Benesch CFO | Feb 21, 2025 | Sale | −1,365 | $5.19 | $7.08K | 45,966 |
| Joseph Benesch CFO | Aug 1, 2024 | Sale | −9,324 | $5.47 | $51.00K | 47,331 |
| Joseph Benesch CFO | Jul 23, 2024 | Sale | −4,055 | $5.40 | $21.90K | 56,655 |
| Michael Cooper Pearce Director | Jul 19, 2024 | Award | +30,000 | – | – | 30,000 |
| Miranda Jayne Toledano Director | Jul 8, 2024 | Award | +9,728 | – | – | 81,445 |
| Neil Herskowitz Director | Jul 8, 2024 | Award | +9,728 | – | – | 81,445 |
| Justin Adam Smith Director | Jul 8, 2024 | Award | +9,728 | – | – | 144,445 |
| Lindsay A. Rosenwald Md Director | Jul 8, 2024 | Award | +9,728 | – | – | 153,973 |
| Joseph Benesch CFO | May 1, 2024 | Award | +80,000 | – | – | 205,966 |
| Claude Maraoui President & CEO, Director | May 1, 2024 | Award | +175,000 | – | – | 2,353,147 |
| Lindsay A. Rosenwald Md Director | Mar 25, 2024 | Buy | +10,000 | $3.04 | $30.40K | 144,245 |
| Lindsay A. Rosenwald Md Director | Mar 22, 2024 | Buy | +20,000 | $3.40 | $68.00K | 134,245 |
| Justin Adam Smith Director | Mar 22, 2024 | Buy | +30,000 | $3.47 | $104.10K | 134,717 |
| Claude Maraoui President & CEO, Director | Mar 22, 2024 | Buy | +10,000 | $3.48 | $34.80K | 2,163,430 |
| Joseph Benesch Interim CFO | Feb 22, 2024 | Sale | −2,450 | $3.75 | $9.19K | 60,710 |
| Joseph Benesch CFO | Jan 3, 2024 | Award | +80,000 | – | – | 125,966 |
| Claude Maraoui President & CEO, Director | Jan 3, 2024 | Award | +175,000 | – | – | 2,178,147 |
| Jeffrey Paley Director | Nov 28, 2023 | Sale | −1,745 | $5.22 | $9.11K | 70,727 |
| Jeffrey Paley Director | Nov 8, 2023 | Sale | −255 | $3.76 | $959 | 114,217 |
| Jeffrey Paley Director | Nov 7, 2023 | Sale | −2,245 | $3.48 | $7.81K | 114,472 |
| Justin Adam Smith Director | Oct 13, 2023 | Buy | +33,000 | $2.98 | $98.34K | 104,717 |
| Jeffrey Paley Director | Oct 6, 2023 | Buy | +15,000 | $2.98 | $44.70K | 72,472 |
| Jeffrey Paley Director | Sep 21, 2023 | Buy | +30,000 | $2.97 | $89.10K | 57,472 |
| Lindsay A. Rosenwald Md Director | Sep 6, 2023 | Buy | +100,000 | $2.23 | $223.00K | 114,245 |
| Claude Maraoui President & CEO, Director | Sep 6, 2023 | Buy | +26,044 | $2.52 | $65.63K | 2,153,430 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.